Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifamurtide in Metastatic and/or Recurrent Osteosarcoma
NCT02441309Phase 2Terminated
- Sponsor
- University of Oxford
- Start
- Oct 2014
- Primary completion
- Nov 2016
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 5
01
Overview
A Phase 2 trial of mifamurtide in osteosarcoma (OS), sponsored by University of Oxford. Started Oct 2014; status: terminated.
02
Drugs
mifamurtide
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT02441309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02441309.